FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, in particular to a composition for inhibiting growth and stimulating apoptosis of cancer cells of colorectal cancer by blocking the function of the MCM4 and Livin genes. Specified composition comprises of a liposome for delivering the composition to target cells and a combination of two duplexes of oligonucleotide siRNA. First duplex is designed to block the genes of MCM4 and contains preparations of small interfering oligonucleotides 5'-C-U-C-A-Umet-C-U-C-U-Umet-A-C-C-C-A-C-A-G-G-dTs-dT-3' as a direct chain and 5'-C-C-U-G-U-G-G-G-Umet-A-A-G-A-G-A-Umet-G-A-G-dTs-dT-3' as an inverse chain. Second duplex is designed to block the genes of Livin and contains preparations of small interfering oligonucleotides 5'-G-G-A-A-G-A-G-A-C-U-Umet-U-G-U-C-C-A-Cmet-A-dTs-dT-3' as a direct chain and 5'-U-G-U-G-G-A-Cmet-A-A-A-G-U-C-Umet-C-U-U-C-C-dTs-dT-3' as an inverse chain. Umet - 2'-O-methyluridin-3'-phosphate; Cmet - 2'-O-methylcytidine-3'-phosphate; dTs - 2'-deoxythymidine-3'-phosphorothioate; dT - 2'-deoxythymidine-3'-phosphate.
EFFECT: invention makes it possible to increase the efficiency of inhibiting the growth and induction of apoptosis in malignant tumor cells, while reducing the side effects.
6 cl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF INDUCING APOPTOSIS OF MALIGNANT TUMOUR CELLS OF COLORECTAL CANCER AND MEANS FOR ITS REALISATION | 2013 |
|
RU2551238C9 |
MIRNA STRUCTURES WITH HIGH ACTIVITY AND REDUCED EXPOSURE OUTSIDE THE TARGET | 2016 |
|
RU2788030C2 |
TRIALKYL CATIONIC LIPIDS AND METHODS FOR USING THEM | 2013 |
|
RU2718053C2 |
OLIGONUCLEOTIDE SEQUENCES AIMED AT THE TRANSCRIPTION FACTOR TSC22D4, FOR TREATING INSULIN RESISTANCE | 2016 |
|
RU2723091C2 |
RNAI AGENTS, COMPOSITIONS AND METHODS FOR USE THEREOF FOR TREATING TRANSTHYRETIN (TTR) ASSOCIATED DISEASES | 2012 |
|
RU2678807C2 |
NUCLEIC ACIDS FOR INHIBITION OF TARGET GENE EXPRESSION CONTAINING PHOSPHODITHIOATE BONDS | 2018 |
|
RU2812806C2 |
I-RNA COMPOSITIONS FOR SERPIN AND METHODS OF USE THEREOF | 2013 |
|
RU2691580C2 |
TREATMENT OF DISEASES, ASSOCIATED WITH PROTEIN OF PROSTATE APOPTOTIC RESPONSE PAR4, BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT OF PAR4 GENE | 2011 |
|
RU2575608C2 |
TREATMENT OF FIBROBLAST GROWTH FACTOR 21 (FGF21) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO FGF21 | 2011 |
|
RU2610661C2 |
TREATMENT OF PYRROLINE-5-CARBOXYLATE REDUCTASE 1 (PYCR1) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO PYCR1 | 2011 |
|
RU2608496C2 |
Authors
Dates
2018-02-13—Published
2016-11-21—Filed